Overview

Renal Hemodynamic Effects of the HMG-CoA Reductase Inhibitors in Normal Volunteers and in Patients With Chronic Renal Failure

Status:
Completed

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This study was done to determine whether Simvastatin (a medication commonly used to treat patients with high cholesterol levels in the blood increases blood flow to the kidneys and improves renal function in normal volunteers and patients with impaired renal function secondary to polycystic kidney diseases.

Phase:

N/A

Details

Lead Sponsor:

Mayo Clinic

Treatments:

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Simvastatin